PRQR
ProQR Therapeutics NV
NASDAQ · Healthcare · Biotechnology · NL
$1.31
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 11.37x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.07x
- Price / sales
- 8.87x
- Price / cash flow
- -3.35x
Enterprise value
- Enterprise value
- $68.3M
- EV / sales
- 3.28x
- EV / EBITDA
- -1.62x
- EV / EBIT
- -1.41x
- Market cap
- $184.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026